Private Prescription: Skip The 6-Month NHS Weight Management Wait
Understanding Wegovy And Mounjaro Equivalent Doses: Key Differences
When comparing Wegovy and Mounjaro equivalent doses, it's essential to understand that these are fundamentally different medications with distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, while Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. This means there isn't a direct 1:1 equivalent dose comparison between the two treatments, as they work through different pathways to support weight management.
The dosing schedules also differ significantly between these prescription-only medicines. Wegovy follows a structured dose escalation from 0.25mg weekly up to 2.4mg maintenance dose over 16 weeks, whilst Mounjaro escalates from 2.5mg to a maximum of 15mg weekly over a different timeframe. Both medications require careful dose titration to minimise side effects and optimise effectiveness, making professional clinical guidance essential when choosing between them.
Private Prescription UK: Transparent Pricing For Wegovy And Mounjaro Doses
EverydayMeds offers transparent pricing for all Wegovy doses, with new customers applying code FIRST40 at checkout and returning customers using DOSE25. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenience for patients planning their dose escalation journey, such as the Intro Duo (0.25mg & 0.5mg) for £169.99.
When considering Wegovy and Mounjaro equivalent doses through private prescription, the total treatment cost varies based on your prescribed regimen and titration speed. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine Novo Nordisk Wegovy with the same quality standards as NHS prescriptions, but delivered within days rather than months. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, offering treatment continuity without repeated ordering.
Clinical Evidence: Wegovy And Mounjaro Equivalent Dose Effectiveness
In clinical trials, patients taking Wegovy alongside diet and exercise achieved an average weight reduction of approximately 15% at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent results across different populations, with STEP 2 showing around 9.6% weight reduction in patients with type 2 diabetes, and STEP 3 achieving approximately 16% with intensive behavioural therapy.
When evaluating Wegovy and Mounjaro equivalent doses, it's important to note that direct head-to-head comparisons aren't available due to different trial designs, populations, and endpoints. Both medications have demonstrated significant weight management benefits in their respective clinical programmes, and the choice between them often depends on individual patient factors, tolerability, and prescriber recommendations based on your clinical assessment.
How Wegovy Works: The GLP-1 Mechanism Behind Dose Effectiveness
Wegovy works as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a natural hormone that regulates appetite and food intake. The medication binds to GLP-1 receptors in your brain's appetite centres, promoting feelings of fullness and reducing hunger signals between meals. This mechanism helps patients feel satisfied with smaller portions and may reduce food cravings, supporting sustainable weight management alongside a reduced-calorie diet and increased physical activity. The dose escalation schedule allows your body to gradually adapt to the medication's effects, minimising gastrointestinal side effects while building therapeutic benefit. Understanding this mechanism helps explain why there's no simple equivalent dose comparison with Mounjaro, as tirzepatide works through additional GIP receptor pathways.
Streamlined Ordering Process For Wegovy And Mounjaro Equivalent Doses
Our private prescription process eliminates the lengthy NHS referral pathway, allowing you to access Wegovy or Mounjaro through a simple 3-minute online clinical assessment. Once submitted, our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), considering factors like your BMI, medical history, and weight management goals. Upon approval, your medication ships via next-day cold-chain delivery, maintaining the strict 2-8°C temperature requirements throughout transit. This streamlined approach means you can start your weight management journey within days rather than waiting 6+ months for NHS specialist weight management services. Both Wegovy and Mounjaro are available through this process, with our prescribers helping determine which option aligns best with your clinical profile.
Storage And Practical Considerations: Wegovy Vs Mounjaro Equivalent Doses
Wegovy offers a storage advantage when comparing equivalent doses with Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This makes Wegovy more convenient for travel or if you accidentally leave your pen out of the fridge. The FlexTouch pen delivery system provides precise dosing with clear graduation marks, and the once-weekly injection schedule helps establish a consistent routine. Both medications require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature stability offers greater flexibility for busy lifestyles. The dose escalation cannot be rushed with either medication, as this increases the risk of gastrointestinal side effects, making the gradual titration schedule an essential safety feature rather than an inconvenience.
Private Prescription Advantages: Wegovy And Mounjaro Equivalent Dose Access
Choosing private prescription for Wegovy and Mounjaro equivalent doses bypasses the restrictive NHS criteria and extensive waiting lists that can delay treatment for months. NHS weight management services typically require BMI ≥35 with comorbidities or BMI ≥40, plus completion of a tier 3 weight management programme before considering medication. Our private service follows the same MHRA licensing criteria but without the additional NHS gatekeeping, meaning eligible patients can access treatment based purely on clinical appropriateness.
The private route also provides continuity of supply, crucial for medications requiring consistent weekly dosing. NHS shortages and supply chain disruptions can interrupt treatment unexpectedly, whilst our private procurement ensures reliable availability of both Wegovy and Mounjaro doses. This consistency is vital for maintaining the therapeutic benefits and avoiding the metabolic disruption that can occur with treatment gaps.
Making Your Choice: Wegovy And Mounjaro Equivalent Doses From EverydayMeds
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which medication aligns best with your clinical profile and treatment goals. Our clinical assessment considers factors beyond simple dose equivalencies, including your medical history, current medications, lifestyle factors, and previous weight management experiences. Starting your assessment today means you could receive your first prescription within days, beginning your weight management journey without the frustration of NHS delays. Apply code FIRST40 at checkout for new customers or DOSE25 for returning patients to access our discounted pricing, and take advantage of our next-day delivery service across the UK. Remember that both medications are prescription-only medicines that must be used alongside a reduced-calorie diet and increased physical activity for optimal results, with ongoing clinical monitoring to ensure safe and effective treatment progression.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
